insights_auto
Why is AGIO down 2.09%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.80
arrow_downward
-2.09%(-0.68) 1D
$31.80
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$32.82
High
$32.82
Low
$31.65
Mkt. cap
1.90B
Avg. vol.
936.41K
Volume
569.93K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.63
Shares outstanding
59.70M
No. of employees
540
Open
$32.82
High
$32.82
Low
$31.65
Mkt. cap
1.90B
Avg. vol.
936.41K
Volume
569.93K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.63
Shares outstanding
59.70M
No. of employees
540
News stories
From web sources and news partners
Zacks
·
2 days ago
Agios' Growth Story Hinges on Mitapivat's Commercial Expansion
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc